Related Experiment Video

Updated: Aug 15, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance

Haizhen Zhu1, David R Nelson, James M Crawford

  • 1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, 32610, USA.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|September 27, 2005
PubMed

Insights

Hepatitis C virus (HCV) resistance to interferon-alpha (IFN-alpha) therapy may stem from host cell defects. Long-term IFN stimulation can alter the Jak-Stat pathway, impacting treatment effectiveness.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Interferon-alpha (IFN-alpha) is a key treatment for viral infections and cancers.
  • Many patients with chronic hepatitis C virus (HCV) infection do not respond to IFN-based therapies.
  • The mechanisms behind HCV's resistance to IFN are not fully understood.

Purpose of the Study:

  • To investigate the cellular mechanisms underlying HCV resistance to IFN-alpha.
  • To determine if host cell signaling pathways are involved in IFN resistance in HCV.

Main Methods:

  • Utilized a HCV subgenomic replicon cell culture system.
  • Examined the role of Signal Transducer and Activator of Transcription 3 (Stat3) activation and Suppressor of Cytokine Signaling 3 (SOCS3) expression.
  • Assessed the impact of Stat3 manipulation and SOCS3 inhibition on IFN sensitivity.

Main Results:

  • Long-term IFN stimulation selected for cells with defective Stat3 activation, leading to IFN resistance.
  • HCV sequence mutations were not found to be responsible for IFN resistance.
  • Restoring Stat3 activation reversed IFN resistance, while dominant-negative Stat3 induced resistance.
  • IFN-resistant cells showed increased SOCS3 expression, and blocking SOCS3 partially restored IFN sensitivity.

Conclusions:

  • HCV IFN resistance in vitro is linked to defective Stat3 activation and increased SOCS3 response, not viral mutations.
  • Long-term IFN treatment selects for host cells with altered Jak-Stat signaling, potentially explaining HCV's therapeutic resistance.

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...